Suggestions
Peter Davis
Business Unit Manager at Boehringer Ingelheim Australia
Professional Background
Peter Davis is a dedicated and experienced Business Unit Head with a robust focus on pharmaceutical strategy. With a commendable career spanning over 30 years, Mr. Davis has an extensive background in identifying commercial opportunities that align with organizational goals and maximizing the reach of life-saving medicines to patients in need. His expertise lies in the successful launch of flagship products across various specialty and primary care fields, including but not limited to, respiratory, neurology, cardiology, endocrinology, rheumatology, and immunology. Mr. Davis is passionate about leading and nurturing high-performing teams to achieve their business and personal potentials, creating an environment where innovation thrives.
Currently, Mr. Davis serves as the Head of the Boehringer Ingelheim Cardiovascular/Metabolism/Renal Business Unit in Australia. In this pivotal role, he encourages the development of multi-skilled team capabilities, fostering a culture where team members are innovative, informed, accountable, and responsible within their strategic and therapeutic domains. His leadership style centers on collaboration, communication, and change management, which he adeptly implements through global marketing strategies and sales management practices.
Education and Achievements
Peter Davis has a solid academic foundation that complements his extensive industry experience. He studied the Global Leadership Development Program at Duke University, which equipped him with invaluable skills in leadership and global market dynamics. Furthermore, he attained a Master's degree in Management with a specialization in Marketing from the Macquarie Graduate School of Management. This combination of education and practical experience positions him as a thought leader in his field, enabling him to navigate the complex landscape of pharmaceutical marketing and business management effectively.
Throughout his illustrious career, Mr. Davis has held various high-profile positions within Boehringer Ingelheim, including the roles of Business Unit Manager for both Cardiovascular/Metabolic and Respiratory segments, and Senior Product Manager for notable products such as Micardis and Spiriva. His journey began at Merck as a Product Manager for Fosamax and progressed through various roles including Sales Analyst, Marketing Analyst, and even a Client Services Manager at IMS Health.
His tenure at AstraZeneca as a Medical Representative and Marketing Analyst further enriched his experience in pharmaceutical sales and marketing, equipping him with a well-rounded perspective of the industry from multiple angles.
Notable Achievements
Peter Davis's career is marked by numerous notable achievements, reflecting his capacity to influence and elevate pharmaceutical strategies within the organizations he has been a part of. He has mastered the art of expanding market share for essential medications, developing innovative strategies that align with patient needs and healthcare provider expectations. His contributions have not only advanced individual product portfolios but have also positively impacted the broader healthcare sphere.
As a leader, he is recognized for cultivating high-performance teams, instilling in them the importance of accountability and strategic thinking. His dedication to personal and team growth has been a driving factor in fostering innovative approaches to various therapeutic areas, significantly benefiting the patients who rely on these life-saving therapies.
Additionally, his comprehensive understanding of change management has poised him as a key player in successfully navigating corporate transformations and restructuring within organizations, demonstrating adaptability and resilience in ever-changing market conditions.
Overall, Peter Davis exemplifies a blend of extensive industry experience, profound knowledge of pharmaceutical strategies, and a commitment to leading high-performing teams. His journey through significant roles in multiple reputable organizations showcases his capability to make impactful contributions in the pharmaceutical sector. As he continues to guide the Boehringer Ingelheim Cardiovascular/Metabolism/Renal Business Unit, Peter Davis remains an influential figure advocating for advancements in healthcare and better therapeutic options for patients.